NLRP3 and type 2 diabetes mellitus: ER stress-related TXNIP/NLRP3 inflammasome activation is involved in the pathophysiology of SAH [60], neonatal hypoxic-ischemic brain injury [20], type 2 diabetes [61], and many other diseases.